Martin B. Brenner
2024
In 2024, Martin B. Brenner earned a total compensation of $1.3M as Chief Executive Officer and Chief Scientific Officer at iBio, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $208,946 |
|---|---|
| Option Awards | $518,286 |
| Salary | $522,365 |
| Other | $21,689 |
| Total | $1,271,286 |
Brenner received $522.4K in salary, accounting for 41% of the total pay in 2024.
Brenner also received $208.9K in non-equity incentive plan, $518.3K in option awards and $21.7K in other compensation.
Rankings
In 2024, Martin B. Brenner's compensation ranked 46th out of 234 executives tracked by ExecPay. In other words, Brenner earned more than 80.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 46 out of 234 | 80th |
Division Manufacturing | 15 out of 98 | 85th |
Major group Chemicals And Allied Products | 5 out of 36 | 86th |
Industry group Drugs | 5 out of 33 | 85th |
Industry Pharmaceutical Preparations | 4 out of 30 | 87th |
Source: SEC filing on October 10, 2024.
Brenner's colleagues
We found one more compensation record of an executive who worked with Martin B. Brenner at iBio in 2024.
2024
Felipe Duran
iBio